Skip to Content

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine

Last Updated: July 28, 2015
Status: Resolved

Products Affected - Description

There are no products affected.

Reason for the Shortage

  • These products are also known as adult tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines.
  • Sanofi-Pasteur has Adacel vials in short supply due to increased demand.
  • Sanofi-Pasteur updated the NDC numbers on the individual vials and syringes (unit of use). The NDC numbers on the outside cartons (unit of sale) remain the same.
  • Adult Tetanus and Diphtheria Toxoids Adsorbed (Td) (Tenivac, Sanofi-Pasteur) is not affected by this shortage.

Available Products

Adacel Vaccine, Sanofi-Pasteur
0.5 mL, single dose syringes, package of 10 (NDC 49281-0400-15)

0.5 mL, single dose vials, package of 10, unit of sale (NDC 49281-0400-10), unit of use (NDC 49281-0400-58)
Boostrix Vaccine, GlaxoSmithKline
0.5 mL, single dose syringes, 10 count (NDC 58160-0842-52)
0.5 mL, single dose vials, 10 count (NDC 58160-0842-11)

Estimated Resupply Dates

All presentations are available.

Related Shortages


July 28, May 20, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.